Results of two phase 2 studies suggest efgartigimod could be a potential treatment for myositis and Sjögren disease in ...

From drug trials to mechanistic insights, EULAR 2025 delivers wide-ranging data that may inform tomorrow’s standards in ...

In the study, Mecoli and colleagues looked at 1086 patients enrolled in the center's Myositis Research Registry from 2003 through 2020. The analysis included patients with a diagnosis of ...

Anti-HMGCR antibodies showed highest predictive value for a myositis diagnosis, followed by anti-MDA5, anti-Jo-1, and anti-TIF1-γ, an analysis of 1068 people with positive myositis antibodies showed.

Cite this: Sporadic Inclusion Body Myositis-Diagnosis, Pathogenesis and Therapeutic Strategies - Medscape - Aug 01, 2006. Summary and Introduction Clinical Features of Sporadic Inclusion Body Myositis ...

Most (68.6%) had myositis-specific autoantibody test results, one of the factors included in the guidelines for determining whether the patient should be classified as low, intermediate, or high risk.

Researchers at Johns Hopkins University School of Medicine have identified a subgroup of patients with necrotizing myopathy who have a novel autoantibody specificity that makes them potential ...

Dermatomyositis and polymyositis are two types of immune-mediated muscle disorders that fall under the umbrella of inflammatory myopathies. Dermatomyositis is more likely to develop during childhood.

Psoriasis Highlights From AAD 2023 Highlights in psoriasis and related disorders from AAD 2023 include data on secukinumab, adalimumab, and deucravacitinib, as reported by Dr Joel Gelfand ...

If we assume that anti-HMGCR autoimmune myopathy is rare (one in 100,000), the negative predictive value of the ELISA test in an unselected population is greater than 0.999.

In patients with dermatomyositis positive for anti-TIF1-γ autoantibodies, the presence of anti-CCAR1 autoantibodies indicate normal rather than elevated cancer risk.

Our understanding of statin-induced myotoxicity is continually expanding. Nevertheless, it would be helpful to predict the likelihood of developing statin myopathy in an individual patient ...